Jacob Licht currently serves as Chief Executive Officer of Exo-Top Inc. and as Vice President of Corporate Development at NurExone. He brings over 20 years of leadership experience in the biotech and specialty pharmaceutical industries. Throughout his career, he has led transactions totaling over $1 billion, spanning mergers and acquisitions, licensing, and asset sales.
Prior to joining NurExone, Jacob held executive positions including Vice President of Business Development at Lantheus Medical Imaging, and Vice President of Corporate Development at Bavarian Nordic and Emergent BioSolutions. In these roles, he was instrumental in scaling operations, driving strategic growth, and executing high-impact commercial partnerships.
Jacob holds extensive expertise in building biotech infrastructure and advancing innovative therapies through critical stages of development and commercialization.
